PET-positive fibrous dysplasia - A potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery

Skeletal Radiology

Volumn 36, Issue SUPPL. 1, 2007, Pages 24-28

  Strobel, Klaus ^a   Bode, Beata ^a   Lardinois, Didier ^a   Exner, Ulrich ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ORTHOPEDIC UNIVERSITY HOSPITAL BALGRIST   (Switzerland)

Author keywords

Fibrous dysplasia; PET CT; Sarcoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTERY INTIMA; ARTICLE; BONE BIOPSY; BONE METASTASIS; BONE RADIOGRAPHY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMUR; FIBROUS DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INCIDENTAL FINDING; LUNG RESECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY ARTERY; SARCOMA; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

ADULT; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FIBROUS DYSPLASIA OF BONE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE IMAGING; MALE; PNEUMONECTOMY; PULMONARY ARTERY; RADIOPHARMACEUTICALS; SARCOMA; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TUNICA INTIMA; VASCULAR NEOPLASMS;

EID: 34248578172     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-006-0152-y     Document Type: Article

References (27)

1. Fitzpatrick KA, Taljanovic MS, Speer DP, et al. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. AJR Am J Roentgenol 2004;182:1389-1398
2. Kransdorf MJ, Moser RP Jr, Gilkey FW. Fibrous dysplasia. Radiographics 1990;10:519-537
3. Sathekge MM, Clauss RP. Criteria and quantification of fibrous dysplasia on MDP scanning. Nuklearmedizin 1995;34:229-231
4. Parekh SG, Donthineni-Rao R, Ricchetti E, Lackman RD. Fibrous dysplasia. J Am Acad Orthop Surg 2004;12:305-313
5. Macapinlac HA. FDG PET and PET/CT imaging in lymphoma and melanoma. Cancer J 2004;10:262-270
6. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507
7. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001;32:191-196
8. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000;27:822-832
9. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat ("USA-Fat"): Description on 18F-FDG PET/CT. J Nucl Med 2003;44:170-176
10. Zhuang H, Sam JW, Chacko TK, et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging 2003;30:1096-1103
11. Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: Assessment by PET/CT. J Nucl Med 2004;45:266-271
12. Lardinois D, Weder W, Roudas M, et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 2005;23:6846-6853
13. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions. Radiology 2001;219:774-777
14. Shigesawa T, Sugawara Y, Shinohara I, Fujii T, Mochizuki T, Morishige I. Bone metastasis detected by FDG PET in a patient with breast cancer and fibrous dysplasia. Clin Nucl Med 2005;30:571-573
15. Toba M, Hayashida K, Imakita S, et al. Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia. Ann Nucl Med 1998;12:153-155
16. Huvos AG, Higinbotham NL, Miller TR. Bone sarcomas arising in fibrous dysplasia. J Bone Joint Surg Am 1972;54:1047-1056
17. Harris WH, Dudley HR Jr, Barry RJ. The natural history of fibrous dysplasia. An orthopaedic, pathological, and roentgenographic study. J Bone Joint Surg Am 1962;44:207-233
18. Present D, Bertoni F, Enneking WF. Osteosarcoma of the mandible arising in fibrous dysplasia. A case report. Clin Orthop 1986;204:238-244
19. Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000;6:1279-1287
20. Eary JF, Conrad EU, Bruckner JD, et al. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998;4:1215-1220
21. Fayad LM, Cohade C, Wahl RL, Fishman EK. Sacral fractures: A potential pitfall of FDG positron emission tomography. AJR Am J Roentgenol 2003;181:1239-1243
22. Shon IH, Fogelman I. F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med 2003;28:171-175
23. Tsuyuguchi N, Ohata K, Morino M, et al. Magnetic resonance imaging and [11C]methyl-L-methionine positron emission tomography of fibrous dysplasia-two case reports. Neurol Med Chir (Tokyo) 2002;42:341-345
24. Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: Evaluation with methionine PET. Radiology 1993;186:45-53
25. Schirrmeister H, Guhlmann A, Elsner K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: Planar bone scintigraphy versus 18F PET. J Nucl Med 1999;40:1623-1629
26. Hetzel M, Arslandemir C, Konig HH, et al. F-18 NaF PET for detection of bone metastases in lung cancer: Accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res 2003;18:2206-2214
27. Langsteger W, Heinisch M, Fogelman I. The Role of Fluorodeoxyglucose, (18)F-Dihydroxyphenylalanine, (18)F-Choline, and (18)F-Fluoride in Bone Imaging with Emphasis on Prostate and Breast. Semin Nucl Med 2006;36:73-92